Literature DB >> 20036466

Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD.

Tanja Jovanovic1, Seth D Norrholm, Nineequa Q Blanding, Justine E Phifer, Tamara Weiss, Michael Davis, Erica Duncan, Bekh Bradley, Kerry Ressler.   

Abstract

A central problem in posttraumatic stress disorder (PTSD) is the inability to suppress fear under safe conditions. We have previously shown that PTSD patients cannot inhibit conditioned fear. Another relevant finding in PTSD is the hypersensitivity of the hypothalamic-pituitary-adrenal (HPA) axis feedback. Given their common neurobiological pathways, alterations in HPA function in PTSD may be associated with impaired fear inhibition. The present study examined the relationship between HPA axis function and fear-potentiated startle and inhibition of conditioned fear in trauma-exposed individuals. We used a conditional discrimination procedure (AX+/BX-), in which one set of shapes (AX+) was paired with aversive airblasts to the throat (danger signal), and the same X shape with a different shape (BX-) were presented without airblasts (safety signal). The paradigm also included a transfer of fear inhibition test (AB). In addition to fear-potentiated startle, blood was drawn for neuroendocrine analysis and the dexamethasone suppression test (DEX) was performed; cortisol and ACTH were assessed at baseline and post-DEX. Ninety highly traumatized individuals recruited from Grady Hospital in Atlanta, GA participated in the study. The sample was divided into those who met DSM-IV criteria for PTSD (n=29) and Non-PTSD controls (n=61) using the PTSD symptom scale (PSS). Both groups showed significant reduction in cortisol and ACTH levels after DEX. Subjects with PTSD had higher fear-potentiated startle to the safety signal, BX- (F(1,88)=4.44, p<0.05) and fear inhibition trials, AB (F(1,88)=5.20, p<0.05), both indicative of less fear inhibition in the presence of B, compared to control subjects. In addition, fear-potentiated startle to AX+, BX-, and AB was positively correlated with baseline and post-DEX ACTH in PTSD subjects. These results suggest that impaired fear inhibition and associated alterations in HPA feedback may reflect amygdala hyperactivity in subjects with PTSD. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036466      PMCID: PMC2875386          DOI: 10.1016/j.psyneuen.2009.11.009

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  48 in total

1.  Comparison of the PTSD Symptom Scale-Interview Version and the Clinician-Administered PTSD scale.

Authors:  E B Foa; D F Tolin
Journal:  J Trauma Stress       Date:  2000-04

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.

Authors:  E Keen-Rhinehart; V Michopoulos; D J Toufexis; E I Martin; H Nair; K J Ressler; M Davis; M J Owens; C B Nemeroff; M E Wilson
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

4.  Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.

Authors:  Y Lee; M Davis
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

5.  Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans.

Authors:  Christian Grillon; Daniel S Pine; Johanna M P Baas; Megan Lawley; Valerie Ellis; Dennis S Charney
Journal:  Psychopharmacology (Berl)       Date:  2005-07-29       Impact factor: 4.530

Review 6.  The neurobiology of startle.

Authors:  M Koch
Journal:  Prog Neurobiol       Date:  1999-10       Impact factor: 11.685

7.  Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.

Authors:  C S de Kloet; E Vermetten; C J Heijnen; E Geuze; E G W M Lentjes; H G M Westenberg
Journal:  Psychoneuroendocrinology       Date:  2007-02-12       Impact factor: 4.905

8.  Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats.

Authors:  P M Plotsky; M J Meaney
Journal:  Brain Res Mol Brain Res       Date:  1993-05

9.  The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder.

Authors:  Rachel Yehuda; Sarah L Halligan; Robert Grossman; Julia A Golier; Cheryl Wong
Journal:  Biol Psychiatry       Date:  2002-09-01       Impact factor: 13.382

10.  In dubio pro defensio: initial activation of conditioned fear is not cue specific.

Authors:  Almut I Weike; Harald T Schupp; Alfons O Hamm
Journal:  Behav Neurosci       Date:  2008-06       Impact factor: 1.912

View more
  41 in total

1.  Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Authors:  Tanja Jovanovic; Erica J Duncan; Joanna Kaye; Kristie Garza; Seth D Norrholm; Sabra S Inslicht; Thomas C Neylan; Sanjay J Mathew; Dan Iosifescu; Barbara O Rothbaum; Helen S Mayberg; Boadie W Dunlop
Journal:  Psychophysiology       Date:  2019-02-26       Impact factor: 4.016

Review 2.  Childhood stressful events, HPA axis and anxiety disorders.

Authors:  Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca
Journal:  World J Psychiatry       Date:  2012-02-22

3.  Dexamethasone Treatment Leads to Enhanced Fear Extinction and Dynamic Fkbp5 Regulation in Amygdala.

Authors:  Takehito Sawamura; Torsten Klengel; Antonio Armario; Tanja Jovanovic; Seth D Norrholm; Kerry J Ressler; Raül Andero
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

Review 4.  Impaired safety signal learning may be a biomarker of PTSD.

Authors:  Tanja Jovanovic; Andrew Kazama; Jocelyne Bachevalier; Michael Davis
Journal:  Neuropharmacology       Date:  2011-03-04       Impact factor: 5.250

5.  Psychophysiology and posttraumatic stress disorder symptom profile in pregnant African-American women with trauma exposure.

Authors:  Vasiliki Michopoulos; Alex O Rothbaum; Elizabeth Corwin; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  Arch Womens Ment Health       Date:  2014-10-03       Impact factor: 3.633

6.  Impact of posttraumatic stress symptom dimensions on amygdala reactivity to emotional faces.

Authors:  Lynne Lieberman; Stephanie M Gorka; Julia A DiGangi; Alyssa Frederick; K Luan Phan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-26       Impact factor: 5.067

7.  Reduced neural activation during an inhibition task is associated with impaired fear inhibition in a traumatized civilian sample.

Authors:  Tanja Jovanovic; Tim Ely; Negar Fani; Ebony M Glover; David Gutman; Erin B Tone; Seth D Norrholm; Bekh Bradley; Kerry J Ressler
Journal:  Cortex       Date:  2012-09-05       Impact factor: 4.027

8.  Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder.

Authors:  Tanja Jovanovic; Justine E Phifer; Katie Sicking; Tamara Weiss; Seth D Norrholm; Bekh Bradley; Kerry J Ressler
Journal:  Psychoneuroendocrinology       Date:  2011-05-20       Impact factor: 4.905

9.  Prevention of stress-impaired fear extinction through neuropeptide s action in the lateral amygdala.

Authors:  Frédéric Chauveau; Maren Denise Lange; Kay Jüngling; Jörg Lesting; Thomas Seidenbecher; Hans-Christian Pape
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

Review 10.  Neural, psychophysiological, and behavioral markers of fear processing in PTSD: a review of the literature.

Authors:  Erel Shvil; Heather L Rusch; Gregory M Sullivan; Yuval Neria
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.